Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

Blood

Volumn 99, Issue 4, 2002, Pages 1442-1448

  Auffermann Gretzinger, Susanne ^a   Lossos, Izidore S ^a   Vayntrub, Tamara A ^a   Leong, Wendy ^a   Carl Grumet, F ^a   Blume, Karl G ^a   Stockerl Goldstein, Keith E ^a   Levy, Ronald ^a   Shizuru, Judith A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGRAFT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL KINETICS; CELL LINEAGE; CELL POPULATION; CELL STRUCTURE; CELL TRANSFER; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0037082478     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1442     Document Type: Article

References (33)

1. Dendritic cells and the control of immunity
2. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen
3. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
4. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
5. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
6. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
7. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies
8. Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies
9. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma
10. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versustumor effects
11. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
12. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
13. Molecular cloning and characterization of a human metalloprotease disintegrin - A novel marker for dendritic cell differentiation
14. + subset of human blood dendritic cells is a direct precursor of Langerhans cells
15. The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses
16. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance
17. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers
18. Mixed chimerism: Preclinical studies and clinical applications
19. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
20. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
21. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha
22. + hematopoietic progenitor cells of the bone marrow and peripheral blood
23. Myeloid dendritic cells
24. Dendritic cells
25. A tumor-associated and self-antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state
26. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
27. Dendritic cell chimerism after allogeneic bone marrow transplantation
28. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
29. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
30. Ligation of CD40 on dendritic cells triggers production of high levels of inteleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
31. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient
32. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
33. Sustaining the graft-versustumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines